EphB and ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells

Stem Cells and Development

Volumn 22, Issue 20, 2013, Pages 2751-2764

  Nguyen, Thao M ^a,b   Arthur, Agnes ^a   Hayball, John D ^b   Gronthos, Stan ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ABELSON KINASE; EPHRIN B1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B4; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

CELL PROLIFERATION; COCULTURE TECHNIQUES; EPHRIN-B2; GENE EXPRESSION REGULATION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MESENCHYMAL STROMAL CELLS; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PRIMARY CELL CULTURE; RECEPTOR, EPHB2; RECEPTOR, EPHB4; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84885121179     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0676     Document Type: Article

References (81)

1. Abumaree M, M Al Jumah, R Pace and B Kalionis. (2012). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev Rep 8:375-392
2. Chen PM, ML Yen, KJ Liu, HK Sytwu and BL Yen. (2011). Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci 18:1-11
3. Wada N, PM Bartold and S Gronthos. (2011). Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Stem Cells Dev 20:647-659
4. Gronthos S and AC Zannettino. (2008). A method to isolate and purify human bone marrow stromal stem cells. Methods Mol Biol 449:45-57
5. Gronthos S, AC Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis and PJ Simmons. (2003). Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835
6. Le Blanc K, C Tammik, K Rosendahl, E Zetterberg and O Ringden. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896
7. Majumdar MK, M Keane-Moore, D Buyaner, WB Hardy, MA Moorman, KR McIntosh and JD Mosca. (2003). Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10:228-241
8. Menicanin D, P Bartold, A Zannettino and S Gronthos. (2009). Genomic profiling of mesenchymal stem cells. Stem Cell Rev Rep 5:36-50
9. Bianco P, M Riminucci, S Gronthos and PG Robey. (2001). Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192
10. François M and J Galipeau. (2012). New insights on translational development of mesenchymal stromal cells for suppressor therapy. J Cell Physiol 227:3535-3538
11. Arthur A, S Koblar, S Shi and S Gronthos. (2009). Eph/ ephrinB mediate dental pulp stem cell mobilization and function. J Dental Res 88:829-834
12. Himanen JP, N Saha and DB Nikolov. (2007). Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol 19:534-542
13. Pasquale EB. (2005). Eph receptor signaling casts a wide net on cell behaviour. Nat Rev 6:462-475
14. Arthur A, A Zannettino, R Panagopoulos, S Kobla, NA Sims, C Stylianou, K Matsuo and S Gronthos. (2011). EphB/ ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone 48:533-542
15. Compagni A, M Logan, R Klein and RH Adams. (2003). Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell 5:217-230
16. Matsuo K and N Otaki. (2012). Bone cell interactions through Eph/ephrin: Bone modeling, remodeling and associated diseases. Cell Adh Migr 6:148-156
17. Mundy GR and F Elefteriou. (2006). Boning up on ephrin signaling. Cell 126:441-443
18. Pasquale EB. (1997). The Eph family of receptors. Curr Opin Cell Biol 9:608-615
19. Kullander K and R Klein. (2002). Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 3:475- 486
20. Murai KK and EB Pasquale. (2003). 'Eph'ective signaling: Forward, reverse and crosstalk. J Cell Sci 116:2823-2832
21. Pasquale EB. (2008). Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38-52
22. Luo H, T Charpentier, X Wang, S Qi, B Han, T Wu, R Terra, A Lamarre and J Wu. (2011). Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling. J Biol Chem 286:41135- 41152
23. Wu J and H Luo. (2005). Recent advances on T-cell regulation by receptor tyrosine kinases. Curr Opin Hematol 12:292-297
24. Munthe E, E Finne and HC Aasheim. (2004). Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells. BMC Immunol 5:9
25. Aasheim HC, L Terstappen and T Logtenberg. (1997). Regulated expression of the eph-related receptor tyrosine kinase Hek11 in early human B lymphopoiesis. Blood 90:3613-3622
26. Prevost N, DS Woulfe, M Tognolini, T Tanaka, W Jian, RR Fortna, H Jiang and LF Brass. (2004). Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1. Blood 103:1348-1355
27. Wohlfahrt JG, C Karagiannidis, S Kunzmann, MM Epstein, W Kempf, K Blaser and CB Schmidt-Weber. (2004). Ephrin- A1 suppresses Th2 cell activation and provides a regulatory link to lung epithelial cells. J Immunol 172:843-850
28. Holen HL, M Shadidi, K Narvhus, O Kjosnes, A Tierens and HC Aasheim. (2008). Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis. J Leukoc Biol 84:1183-1191
29. Luo H, G Yu, Y Wu and J Wu. (2002). EphB6 crosslinking results in costimulation of T cells. J Clin Invest 110:1141-1150
30. Aasheim HC, J Delabie and EF Finne. (2005). Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood 105:2869- 2876
31. Luo H, G Yu, J Tremblay and J Wu. (2004). EphB6-null mutation results in compromised T cell function. J Clin Invest 114:1762-1773
32. Yu G, H Luo, Y Wu and J Wu. (2004). EphrinB1 is essential in T-cell-T-cell co-operation during T-cell activation. J Biol Chem 279:55531-55539
33. Yu G, H Luo, Y Wu and J Wu. (2003). Ephrin B2 induces T cell costimulation. J Immunol 171:106-114
34. Kitamura T, Y Kabuyama, A Kamataki, MK Homma, H Kobayashi, S Aota, S Kikuchi and Y Homma. (2008). Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis. Am J Physiol Cell Physiol 294:C189-C196
35. Kawano H, Y Katayama, K Minagawa, M Shimoyama, M Henkemeyer and T Matsui. (2012). A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition. Eur J Immunol 42:1562-1572
36. Pittenger MF, AM Mackay, SC Beck, RK Jaiswa, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
37. Wada N, D Menicanin, S Shi, PM Bartold and S Gronthos. (2009). Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol 219:667-676
38. Diamond P, A Labrinidis, SK Martin, AN Farrugia, S Gronthos, LB To, N Fujii, PD O'Loughlin, A Evdokiou and ACW Zannettino. (2009). Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. J Bone Miner Res 24:1150- 1161
39. Tanaka M, R Kamata, K Yanagihara and R Sakai. (2010). Suppression of gastric cancer dissemination by ephrin-B1- derived peptide. Cancer Sci 101:87-93
40. Stagg J, J Galipeau, K Kauser and A-M Zeiher. (2007). Immune Plasticity of Bone Marrow-Derived Mesenchymal Stromal Cells Bone Marrow-Derived Progenitors. Springer Berlin Heidelberg, Montreal QC, Canada, pp 45-66
41. Alfaro D, JJ García-Ceca, T Cejalvo, E Jiménez, EJ Jenkinson, G Anderson, JJ Muñoz and A Zapata. (2007). EphrinB1- EphB signaling regulates thymocyte-epithelium interactions involved in functional T cell development. Eur J Immunol 37:2596-2605
42. Yu G, J Mao, Y Wu, H Luo and J Wu. (2006). Ephrin-B1 is critical in T-cell development. J Biol Chem 281:10222-10229
43. Mendez-Ferrer S, TV Michurina, F Ferraro, AR Mazloom, BD MacArthur, SA Lira, DT Scadden, A Ma'ayan, GN Enikolopov and PS Frenette. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834
44. Bähr M and P Lingor. (2009). Axonal regeneration: Role of growth and guidance cues. In: Encyclopedia of Neuroscience. Binder, Marc D., Hirokawa, Nobutaka, Windhorst, Uwe, eds. Academic Press, Oxford, pp 1163-1172
45. Feng G, MB Laskowski, DA Feldheim, H Wang, R Lewis, J Frisen, JG Flanagan and JR Sanes. (2000). Roles for ephrins in positionally selective synaptogenesis between motor neurons and muscle fibers. Neuron 25:295-306
46. Flanagan JG and P Vanderhaeghen. (1998). The ephrins and Eph receptors in neural development. Annu Rev Neurosci 21:309-345
47. Hamada K, Y Oike, Y Ito, H Maekawa, K Miyata, T Shimomura and T Suda. (2003). Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. Arterioscler Thromb Vasc Biol 23:190-197
48. Kim I, YS Ryu, HJ Kwak, SY Ahn, J-L Oh, GD Yancopoulos, NW Gale and GY Koh. (2002). EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin-1-induced Ras/ mitogen-activated protein kinase pathway in venous endothelial cells. FASEB J 16:1126-1128
49. Noren NK, M Lu, AL Freeman, M Koolpe and EB Pasquale. (2004). Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A 101:5583-5588
50. Koolpe M, R Burgess, M Dail and EB Pasquale. (2005). EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem 280:17301-17311
51. Chrencik JE, A Brooun, MI Recht, G Nicola, LK Davis, R Abagyan, H Widmer, EB Pasquale and P Kuhn. (2007). Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. J Biol Chem 282:36505-36513
52. Himanen J-P, MJ Chumley, M Lackmann, C Li, WA Barton, PD Jeffrey, C Vearing, D Geleick, DA Feldheim, et al. (2004). Repelling class discrimination: Ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 7:501-509
53. Himanen J-P, KR Rajashankar, M Lackmann, CA Cowan, M Henkemeyer and DB Nikolov. (2001). Crystal structure of an Eph receptor-ephrin complex. Nature 414:933-938
54. Chrencik JE, A Brooun, ML Kraus, MI Recht, AR Kolatkar, GW Han, JM Seifert, H Widmer,M Auer and P Kuhn. (2006). Structural and biophysical characterization of the EphB4$EphrinB2 protein-protein interaction and receptor specificity. J Biol Chem 281:28185-28192
55. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood 101:3722-3729
56. Sensebé L, M Krampera, H Schrezenmeier, P Bourin and R Giordano. (2010). Mesenchymal stem cells for clinical application. Vox Sanguinis 98:93-107
57. Tse WT, JD Pendleton, WM Beyer, MC Egalka and EC Guinan. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75:389-397
58. Alfaro D, JJ Muñoz, J García-Ceca, T Cejalvo, E Jiménez and A Zapata. (2008). Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment. Immunology 125:131-143
59. Ramasamy R, CK Tong, HF Seow, S Vidyadaran and F Dazzi. (2008). The immunosuppressive effects of human bone marrow- derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 251:131-136
60. Kumamoto T, S Togo, A Ishibe, D Morioka, K Watanabe, T Takahashi, T Shimizu, K-i Matsuo, T Kubota, et al. (2008). Role of nitric oxide synthesized by nitric oxide synthase 2 in liver regeneration. Liver Int 28:865-877
61. Steinle JJ, CJ Meininger, U Chowdhury, G Wu and HJ Granger. (2003). Role of ephrin B2 in human retinal endothelial cell proliferation and migration. Cell Signal 15:1011- 1017
62. Steinle JJ, CJ Meininger, R Forough, G Wu, MH Wu and HJ Granger. (2002). Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem 277:43830- 43835
63. Krampera M, A Pasini, G Pizzolo, L Cosmi, S Romagnani and F Annunziato. (2006). Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol 6:435-441
64. Miao H and B Wang. (2009). Eph/ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol 41:762-770
65. McCoy ME, FD Finkelman and DB Straus. (2010). Th2- specific immunity and function of peripheral T cells is regulated by the p56Lck Src homology 3 domain. J Immunol 185:3285-3294
66. Sharfe N, A Freywald, A Toro and CM Roifman. (2003). Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol 170:6024-6032
67. Gu C and S Park. (2001). The EphA8 receptor regulates integrin activity through p110g phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol Cell Biol 21:4579-4597
68. Maddigan A, L Truitt, R Arsenault, T Freywald, O Allonby, J Dean, A Narendran, J Xiang, A Weng, S Napper and A Freywald. (2011). EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes. J Immunol 187:5983-5994
69. Noren NK, G Foos, CA Hauser and EB Pasquale. (2006). The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 8:815-825
70. Xu Z, KO Lai, HM Zhou, SC Lin and NY Ip. (2003). Ephrin- B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation. J Biol Chem 278:24767-24775
71. Huynh-Do U, C Vindis, H Liu, DP Cerretti, JT McGrew, M Enriquez, J Chen and TO Daniel. (2002). Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J Cell Sci 115:3073-3081
72. Burns JC, E Corbo, J Degen, M Gohil, C Anterasian, B Schraven, GA Koretzky, S Kliche and MS Jordan. (2011). The SLP-76 Src homology 2 domain is required for T cell development and activation. J Immunol 187:4459-4466
73. Gu JJ, JR Ryu and AM Pendergast. (2009). Abl tyrosine kinases in T-cell signaling. Immunol Rev 228:170-183
74. Martin-Sanchez E, SM Rodriguez-Pinilla, M Sanchez-Beato, L Lombardia, B Dominguez-Gonzalez, D Romero, L Odqvist, P Garcia-Sanz, MB Wozniak, et al. (2013). Simultaneous pan-PI3K and MEK inhibition as a potential therapeutic strategy in peripheral T cell lymphomas. Haematologica 98:57-64
75. Mujib S, RB Jones, C Lo, N Aidarus, K Clayton, A Sakhdari, E Benko, C Kovacs and MA Ostrowski. (2012). Antigen-independent induction of Tim-3 expression on human T cells by the common g-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway. J Immunol 188:3745- 3756
76. Sabapathy K, Y Hu, T Kallunki, M Schreiber, JP David, W Jochum, EF Wagner and M Karin. (1999). JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol 9:116-125
77. Sabapathy K, T Kallunki, JP David, I Graef, M Karin and EF Wagner. (2001). C-Jun Nh2-terminal kinase (Jnk)1 and Jnk2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 193:317-328
78. Silberman I, RV Sionov, V Zuckerman, S Haupt, Z Goldberg, A Strasser, ZS Ben-Sasson, M Baniyash, AJ Koleske and Y Haupt. (2008). T cell survival and function requires the c-Abl tyrosine kinase. Cell Cycle 7:3847-3857
79. So L and DA Fruman. (2012). PI3K signalling in B- and Tlymphocytes: New developments and therapeutic advances. Biochem J 442:465-481
80. Wu W and LJ Berg. (2008). c-Abl, an additional tyrosine kinase required for T cell development and function. Cell Cycle 7:3791
81. Holmberg J, DL Clarke and J Frisen. (2000). Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 408:203-206